Literature DB >> 23756768

Analysis of a rare functional truncating mutation rs61757459 in vaspin (SERPINA12) on circulating vaspin levels.

Jana Breitfeld1, John T Heiker, Yvonne Böttcher, Dorit Schleinitz, Anke Tönjes, Kerstin Weidle, Kerstin Krause, E Bartholomeus Kuettner, Markus Scholz, Wieland Kiess, Norbert Sträter, Annette G Beck-Sickinger, Michael Stumvoll, Antje Körner, Matthias Blüher, Peter Kovacs.   

Abstract

UNLABELLED: A recent genome-wide association study suggests that genetic variation within the vaspin gene might contribute to the variability in circulating serum visceral adipose tissue-derived serine protease inhibitor (vaspin) concentrations. Here, we analyzed the functional consequences of the rare variant rs61757459 predicting a premature stop codon and its impact on circulating serum vaspin concentrations. In order to identify genetic variation, we sequenced the vaspin gene in 48 nonrelated Caucasian subjects. Rs61757459 was subsequently genotyped in three metabolically well-characterized German cohorts (N = 4,019). We addressed the impact of rs61757459 on the crystal structure of vaspin and investigated its effects on vaspin expression in vivo as well as in vitro using various cell lines (Escherichia coli, HEK293). Along with previously reported common genetic variants, sequencing of vaspin revealed a rare variant (rs61757459; minor allele frequency: 1 %) which predicts a premature stop codon p.R211X. Heterozygous carriers of this mutation had lower circulating vaspin levels when compared with noncarriers. In silico structure analysis of the truncated vaspin, which was estimated to be 24.5 kDa, suggested misfolding and potential instability due to the absence of core structural domains. Indeed, the truncated protein was detected after recombinant expression in E. coli and in lysate, but not in supernatant of HEK293 cells. We conclude that rs61757459 is a functional mutation that results in a truncated protein whose instability likely results in reduced serum vaspin levels. KEY MESSAGE: A rare variant (rs61757459) in vaspin coding for the stop codon p.R211X is related to lower circulating vaspin concentrations. Structure analysis suggests misfolding and instability due to the absence of core structural domains. The truncated protein is detectable after recombinant expression in E. coli and in lysate, but not in supernatant of HEK293 cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23756768     DOI: 10.1007/s00109-013-1062-9

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  24 in total

1.  Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans.

Authors:  Yvonne Böttcher; Daniel Teupser; Beate Enigk; Janin Berndt; Nora Klöting; Michael R Schön; Joachim Thiery; Matthias Blüher; Michael Stumvoll; Peter Kovacs
Journal:  J Clin Endocrinol Metab       Date:  2006-04-24       Impact factor: 5.958

2.  PAML 4: phylogenetic analysis by maximum likelihood.

Authors:  Ziheng Yang
Journal:  Mol Biol Evol       Date:  2007-05-04       Impact factor: 16.240

3.  Genetic variation in the Sorbs of eastern Germany in the context of broader European genetic diversity.

Authors:  Krishna R Veeramah; Anke Tönjes; Peter Kovacs; Arnd Gross; Daniel Wegmann; Patrick Geary; Daniela Gasperikova; Iwar Klimes; Markus Scholz; John Novembre; Michael Stumvoll
Journal:  Eur J Hum Genet       Date:  2011-05-11       Impact factor: 4.246

4.  Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects.

Authors:  N Klöting; P Kovacs; M Kern; J T Heiker; M Fasshauer; M R Schön; M Stumvoll; A G Beck-Sickinger; M Blüher
Journal:  Diabetologia       Date:  2011-04-05       Impact factor: 10.122

5.  Genetic variation in the vaspin gene affects circulating serum vaspin concentrations.

Authors:  J Breitfeld; A Tönjes; Y Böttcher; D Schleinitz; N Wiele; C Marzi; C Brockhaus; W Rathmann; C Huth; H Grallert; T Illig; M Blüher; P Kovacs; M Stumvoll
Journal:  Int J Obes (Lond)       Date:  2012-08-21       Impact factor: 5.095

6.  Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: Results from the MONICA/KORA studies.

Authors:  K Kempf; B Rose; T Illig; W Rathmann; K Strassburger; B Thorand; C Meisinger; H-E Wichmann; C Herder; C Vollmert
Journal:  Exp Clin Endocrinol Diabetes       Date:  2008-08-25       Impact factor: 2.949

7.  Genetic variation in GPR133 is associated with height: genome wide association study in the self-contained population of Sorbs.

Authors:  Anke Tönjes; Moritz Koriath; Dorit Schleinitz; Kerstin Dietrich; Yvonne Böttcher; Nigel W Rayner; Peter Almgren; Beate Enigk; Olaf Richter; Silvio Rohm; Antje Fischer-Rosinsky; Andreas Pfeiffer; Katrin Hoffmann; Knut Krohn; Gabriela Aust; Joachim Spranger; Leif Groop; Matthias Blüher; Peter Kovacs; Michael Stumvoll
Journal:  Hum Mol Genet       Date:  2009-09-03       Impact factor: 6.150

8.  Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.

Authors:  Nicole Soranzo; Serena Sanna; Eleanor Wheeler; Christian Gieger; Dörte Radke; Josée Dupuis; Nabila Bouatia-Naji; Claudia Langenberg; Inga Prokopenko; Elliot Stolerman; Manjinder S Sandhu; Matthew M Heeney; Joseph M Devaney; Muredach P Reilly; Sally L Ricketts; Alexandre F R Stewart; Benjamin F Voight; Christina Willenborg; Benjamin Wright; David Altshuler; Dan Arking; Beverley Balkau; Daniel Barnes; Eric Boerwinkle; Bernhard Böhm; Amélie Bonnefond; Lori L Bonnycastle; Dorret I Boomsma; Stefan R Bornstein; Yvonne Böttcher; Suzannah Bumpstead; Mary Susan Burnett-Miller; Harry Campbell; Antonio Cao; John Chambers; Robert Clark; Francis S Collins; Josef Coresh; Eco J C de Geus; Mariano Dei; Panos Deloukas; Angela Döring; Josephine M Egan; Roberto Elosua; Luigi Ferrucci; Nita Forouhi; Caroline S Fox; Christopher Franklin; Maria Grazia Franzosi; Sophie Gallina; Anuj Goel; Jürgen Graessler; Harald Grallert; Andreas Greinacher; David Hadley; Alistair Hall; Anders Hamsten; Caroline Hayward; Simon Heath; Christian Herder; Georg Homuth; Jouke-Jan Hottenga; Rachel Hunter-Merrill; Thomas Illig; Anne U Jackson; Antti Jula; Marcus Kleber; Christopher W Knouff; Augustine Kong; Jaspal Kooner; Anna Köttgen; Peter Kovacs; Knut Krohn; Brigitte Kühnel; Johanna Kuusisto; Markku Laakso; Mark Lathrop; Cécile Lecoeur; Man Li; Mingyao Li; Ruth J F Loos; Jian'an Luan; Valeriya Lyssenko; Reedik Mägi; Patrik K E Magnusson; Anders Mälarstig; Massimo Mangino; María Teresa Martínez-Larrad; Winfried März; Wendy L McArdle; Ruth McPherson; Christa Meisinger; Thomas Meitinger; Olle Melander; Karen L Mohlke; Vincent E Mooser; Mario A Morken; Narisu Narisu; David M Nathan; Matthias Nauck; Chris O'Donnell; Konrad Oexle; Nazario Olla; James S Pankow; Felicity Payne; John F Peden; Nancy L Pedersen; Leena Peltonen; Markus Perola; Ozren Polasek; Eleonora Porcu; Daniel J Rader; Wolfgang Rathmann; Samuli Ripatti; Ghislain Rocheleau; Michael Roden; Igor Rudan; Veikko Salomaa; Richa Saxena; David Schlessinger; Heribert Schunkert; Peter Schwarz; Udo Seedorf; Elizabeth Selvin; Manuel Serrano-Ríos; Peter Shrader; Angela Silveira; David Siscovick; Kjioung Song; Timothy D Spector; Kari Stefansson; Valgerdur Steinthorsdottir; David P Strachan; Rona Strawbridge; Michael Stumvoll; Ida Surakka; Amy J Swift; Toshiko Tanaka; Alexander Teumer; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Anke Tönjes; Gianluca Usala; Veronique Vitart; Henry Völzke; Henri Wallaschofski; Dawn M Waterworth; Hugh Watkins; H-Erich Wichmann; Sarah H Wild; Gonneke Willemsen; Gordon H Williams; James F Wilson; Juliane Winkelmann; Alan F Wright; Carina Zabena; Jing Hua Zhao; Stephen E Epstein; Jeanette Erdmann; Hakon H Hakonarson; Sekar Kathiresan; Kay-Tee Khaw; Robert Roberts; Nilesh J Samani; Mark D Fleming; Robert Sladek; Gonçalo Abecasis; Michael Boehnke; Philippe Froguel; Leif Groop; Mark I McCarthy; W H Linda Kao; Jose C Florez; Manuela Uda; Nicholas J Wareham; Inês Barroso; James B Meigs
Journal:  Diabetes       Date:  2010-09-21       Impact factor: 9.461

9.  Vaspin is an adipokine ameliorating ER stress in obesity as a ligand for cell-surface GRP78/MTJ-1 complex.

Authors:  Atsuko Nakatsuka; Jun Wada; Izumi Iseda; Sanae Teshigawara; Kanji Higashio; Kazutoshi Murakami; Motoko Kanzaki; Kentaro Inoue; Takahiro Terami; Akihiro Katayama; Kazuyuki Hida; Jun Eguchi; Chikage Sato Horiguchi; Daisuke Ogawa; Yasushi Matsuki; Ryuji Hiramatsu; Hideo Yagita; Shigeru Kakuta; Yoichiro Iwakura; Hirofumi Makino
Journal:  Diabetes       Date:  2012-07-26       Impact factor: 9.461

10.  Role of vaspin in human eating behaviour.

Authors:  Jana Breitfeld; Anke Tönjes; Marie-Therese Gast; Dorit Schleinitz; Matthias Blüher; Michael Stumvoll; Peter Kovacs; Yvonne Böttcher
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more
  1 in total

Review 1.  Genetic Determination of Serum Levels of Diabetes-Associated Adipokines.

Authors:  Dorit Schleinitz
Journal:  Rev Diabet Stud       Date:  2016-01-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.